Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long-noncoding transcriptome [GRO-seq]

ABSTRACT: Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long-noncoding transcriptome [GRO-seq]

PROVIDER: PRJNA851415 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19768312.fastq.gz	Fastqsanger.gz
	SRR19768313.fastq.gz	Fastqsanger.gz
	SRR19768314.fastq.gz	Fastqsanger.gz
	SRR19768315.fastq.gz	Fastqsanger.gz
	SRR19768316.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 44

Similar Datasets

Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long-noncoding transcriptome [GRO-seq]

Project description:Aberrant Wnt pathway activation is the key driver of colorectal cancer (CRC) development and essential to sustain tumour growth and progression. Although the downstream protein-coding target genes of the Wnt cascade have been well-defined, the long non-coding transcriptome (lncRNAs) has not been resolved in similar detail. We here use global run-on sequencing (GROseq) to define a set of non-coding transcripts that are regulated by the β-catenin/TCF transcriptional complex in CRC.

2023-07-01 | GSE206582 | GEO

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities [CRISPRseries]

Project description:Long noncoding RNAs (lncRNAs) are widely dysregulated in cancer, yet their functional roles in cellular disease hallmarks remain unclear. Here we employ pooled CRISPR deletion to perturb 831 lncRNAs detected in KRAS-mutant non-small cell lung cancer (NSCLC), and measure their contribution to proliferation, chemoresistance and migration across two cell backgrounds. Integrative analysis of this data outperforms conventional “dropout” screens in identifying cancer genes, while prioritising disease-relevant lncRNAs with pleiotropic and background-independent roles. Altogether 80 high-confidence oncogenic lncRNAs are active in NSCLC, the majority identified here for the first time, and which tend to be amplified and overexpressed in tumours. A follow-up antisense oligonucleotide (ASO) screen shortlisted two candidates, Cancer Hallmarks in Lung LncRNA 1 (CHiLL 1) and GCAWKR, whose knockdown consistently suppressed cancer hallmarks in a variety of two- and three-dimension tumour models. Molecular phenotyping reveals that CHiLL 1 and GCAWKR control cellular-level phenotypes via distinct transcriptional networks converging on common oncogenic pathways. In summary, this work reveals a multi-dimensional functional lncRNA landscape underlying NSCLC that contains potential therapeutic vulnerabilities.

2022-07-05 | GSE207228 | GEO

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities [ASOseries]

2022-07-05 | GSE207227 | GEO

Identifying target genes for the long noncoding RNA, GATA2-AS1

Project description:Identifying target genes for the long noncoding RNA, GATA2-AS1

| PRJNA810047 | ENA

Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients

Project description:1. Evaluate the diagnostic value of long noncoding RNA (CCAT1) expression by RT-PCR in peripheral blood in colorectal cancer patients versus normal healthy control personal. 2. Evaluate the clinical utility of detecting long noncoding RNA (CCAT1) expression in diagnosis of colorectal cancer patients & its relation to tumor staging. 3. Evaluate the clinical utility of detecting long noncoding RNA (CCAT1) expression in precancerous colorectal diseases. 4. Compare long noncoding RNA (CCAT1) expression with traditional marker; carcinoembryonic antigen (CEA) and Carbohydrate antigen 19-9 (CA19-9) in diagnosis of colorectal cancer.

| 2330122 | ecrin-mdr-crc

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities.

Project description:Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities.

| PRJNA854193 | ENA

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities [ASOseries]

Project description:Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities [ASOseries]

| PRJNA854198 | ENA

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities [CRISPRseries]

Project description:Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities [CRISPRseries]

| PRJNA854197 | ENA

GRO-seq in human CD34+ erythrocytes

Project description:Purpose: GRO-seq is a robust method to examine the nascent RNA transcriptome in the genome level Methods: The GRO-seq measures the trancription of nascent RNAs in the genome. From human CD34+ erythrocytes treated with veichle or T4 we conducted GRO-seq to examine the transcripome.

2017-09-06 | GSE102819 | GEO

GRO-seq in HeLa cells

Project description:Mapping the nascent RNA transcriptome of HeLa cells with GRO-seq Standard GRO-seq assay from two replicates in HeLa cells

2014-10-04 | E-GEOD-62046 | biostudies-arrayexpress